openPR Logo
Press release

Hepatitis B Vaccines Market Growth Analysis 2021

11-15-2017 11:59 AM CET | Health & Medicine

Press release from: Persistance Market Research

Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis B vaccine refers to a vaccine that is developed for prevention of hepatitis B virus infection. Hepatitis B vaccine consists of viral envelope proteins and hepatitis B surface antigens (HBsAg). Hepatitis B vaccine is produced by using yeast cells. Medication course for hepatitis B vaccine consists of two or three injections.

These injections are given at a time interval of about one month. The first and second doses provide full protection against infection. Final or third injection is given to prolong the effect of hepatitis B vaccine. As a result of this medication, an immune system is developed in the patient’s body which produces an antibody to HBsAg. This antibody is called as anti-HBs. This antibody provides protection against hepatitis B infection. In addition, immune system memory helps to provide resistance against hepatitis B virus. The global market for hepatitis B vaccine is growing at a significant rate due to increasing number of cases with hepatitis B infection. In addition, growing population and growing awareness for improved healthcare facilities is increasing the global market for hepatitis B vaccine. Various types of hepatitis B vaccines are available in the market, such as recombinant DNA vaccines that is produced by insertion of hepatitis B virus.

Request a sample of this report -
https://www.persistencemarketresearch.com/samples/3600

North America dominates the global hepatitis B vaccines market due to increasing prevalence of hepatitis B infection cases and improved healthcare facilities in the region. In addition, government initiatives and more awareness among the people are some of the major factors driving the hepatitis B vaccines market. Asia, followed by Europe, is expected to experience high growth rate in the next few years in hepatitis B vaccines market. China and India are expected to be the fastest growing hepatitis B vaccines markets in Asian region. This is due to large investment by various major companies in these countries. Some of the key driving forces for hepatitis B vaccines market in emerging countries are large pool of patients, rising government funding and improvement in the healthcare facilities.

One of the major factors driving the global hepatitis B vaccines market includes increasing number of hepatitis B infection cases. In addition, increasing awareness about the treatment of disease and government initiatives are driving the global hepatitis B vaccines market. However, some of the factors such as high cost and non-willingness by people for any kind of vaccination are restraining the global hepatitis B vaccines market.

Growing demographics and economies in the developing countries such as India and China are expected to offer good opportunities for global hepatitis B vaccines market. In addition, growing awareness and innovation of some new type of medications with better efficiency are expected to offer good opportunity for global hepatitis B vaccines market. Inadequate coverage of vaccines is one of the major challenges faced by global pediatric interventional cardiology devices market. Some of the latest trends that have been observed in global hepatitis B vaccines market include companies involved in mergers and acquisitions. In addition, it has been observed that companies are involved in R&D and product launches of more efficient products.

Request a ToC of this report -
https://www.persistencemarketresearch.com/toc/3600

Some of the major companies involved in global hepatitis B vaccines market are Merck, GlaxoSmithKline, Sanofi Pasteur and Human Biologicals Institute, a division of Indian Immunologicals Limited. Some other companies dealing having significant presence in the global hepatitis B vaccines market are Dynavax Technologies, LG Life Sciences, Janssen Pharmaceuticals and Kaketsuke.

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hepatitis B Vaccines Market Growth Analysis 2021 here

News-ID: 818143 • Views: 233

More Releases from Persistance Market Research

Asian Food Market Anticipated to Grow at a Significant Pace by 2021
Asian foods consist of Chinese, Thai and Indian food. It has become extremely popular in Fast food segment in western countries as it is believed to be more nutritious than conventional fast food such as burgers, pizza, pasta, burritos, taco and sandwiches. The market is highly fragmented worldwide and many small players operate as exclusive restaurants or as chained restaurants. The Asian food systems market across the globe is expected
Global Dehydrated Food Market Revenue to Record Robust Growth in the Years After …
Drying or dehydration is a process through which moisture or water content is removed from the food. Removing of water content from food makes them lighter and smaller. It helps in preservation of food for longer period of time. Dehydrated food do not require any refrigeration while preserving at home or at the time of consumption. Moreover, dehydrated food is ideal for preserving seasonal fruits and vegetables. Dehydrated food offer
Global Beauty Supplements Market to Witness Significant Revenue Growth on Back o …
Supplements comprise those products which are used to improve, enhance and – offer support to any kind of deficiency in the human body. Supplements are generally offered to the consumers in the form of pills, capsules, softgels or in powdered or liquid form. Supplements can be segmented on the basis of type which includes herbal supplements and natural supplements. Furthermore, supplements can be segmented on the basis of application which
Confectionery Market by 2021: Complete Analysis of Key Players, Growth Rate, Opp …
The confectionery market is one of the growing sectors globally . Usually, confections are low in nutrients and high in calorie. Sugar-free confections are gaining popularity in the recent years due to factors such as increasing obesity rate, increasing number of diabetic patients, increasing nutritional and health concerns, and changing lifestyle. The confectionery market can be primarily divided into two broad categories: sugar confectionery and bakers’ confectionery . Sugar confectionery

All 5 Releases


More Releases for Hepatitis

Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis C Drugs Market trend, outlook 2025
Hepatitis C virus is a blood-borne virus that infects liver cells, resulting in illness that ranges from mild and transient effects such as easy bleeding, fatigue, yellow discoloration of skin and eyes, and others to chronic and serious life-threatening conditions such as liver cirrhosis, liver cancer or liver failure. Hepatitis C virus is transmitted through needlestick injuries, organ transplant from a carrier, sexually or from infected mother to fetus. Globally,
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each